NasdaqGM - Nasdaq Real Time Price USD
Rhythm Pharmaceuticals, Inc. (RYTM)
Tune into earnings calls Now streaming directly on quote pages.
60.72
-3.91
(-6.05%)
At close: 4:00:00 PM EDT
60.72
0.00
(0.00%)
After hours: 7:00:20 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 373,949 | 24 |
| Sales | 326,859 | 28 |
| Net Shares Purchased (Sold) | 47,090 | 52 |
| Total Insider Shares Held | 396.84k | -- |
| % Net Shares Purchased (Sold) | 13.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 6.80 per share. | Direct | 47,811 | Apr 29, 2025 |
| MAZABRAUD YANN Officer | Sale at price 65.08 per share. | Direct | 438,946 | Apr 29, 2025 |
| CRAMER PAMELA J. Officer | Sale at price 65.09 per share. | Direct | 457,663 | Apr 29, 2025 |
| MAZABRAUD YANN Officer | -- | Direct | -- | Apr 15, 2025 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 6.80 - 27.35 per share. | Direct | 278,853 | Apr 8, 2025 |
| MAZABRAUD YANN Officer | Sale at price 60.37 - 61.54 per share. | Direct | 1,082,497 | Apr 8, 2025 |
| CRAMER PAMELA J. Officer | Sale at price 58.36 - 62.00 per share. | Direct | 1,248,490 | Apr 8, 2025 |
| GERMAN CHRISTOPHER PAUL Officer | Sale at price 54.23 per share. | Direct | 18,655 | Mar 21, 2025 |
| GERMAN CHRISTOPHER PAUL Officer | -- | Direct | -- | Mar 20, 2025 |
| MAZABRAUD YANN Officer | Conversion of Exercise of derivative security at price 22.28 per share. | Direct | 1,671,000 | Mar 14, 2025 |
| MAZABRAUD YANN Officer | Sale at price 50.79 - 51.72 per share. | Direct | 3,861,272 | Mar 14, 2025 |
| LEE JENNIFER KAYDEN Officer | Sale at price 57.22 per share. | Direct | 116,443 | Feb 19, 2025 |
| CRAMER PAMELA J. Officer | Sale at price 57.22 per share. | Direct | 56,190 | Feb 19, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 57.22 per share. | Direct | 70,266 | Feb 19, 2025 |
| GERMAN CHRISTOPHER PAUL Officer | Sale at price 57.22 per share. | Direct | 36,335 | Feb 19, 2025 |
| MEEKER DAVID P Chief Executive Officer | Sale at price 57.22 per share. | Direct | 566,249 | Feb 19, 2025 |
| SMITH HUNTER C Chief Financial Officer | Sale at price 57.22 per share. | Direct | 126,742 | Feb 19, 2025 |
| MEEKER DAVID P Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
| CRAMER PAMELA J. Officer | -- | Direct | -- | Feb 14, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
| GERMAN CHRISTOPHER PAUL Officer | -- | Direct | -- | Feb 14, 2025 |
| SMITH HUNTER C Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| MAZABRAUD YANN Officer | -- | Direct | -- | Feb 14, 2025 |
| LEE JENNIFER KAYDEN Officer | -- | Direct | -- | Feb 14, 2025 |
| LEE JENNIFER KAYDEN Officer | Sale at price 56.39 - 58.00 per share. | Direct | 172,238 | Feb 13, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 56.39 - 57.09 per share. | Direct | 26,452 | Feb 12, 2025 |
| SMITH HUNTER C Chief Financial Officer | Sale at price 56.22 - 56.39 per share. | Direct | 42,347 | Feb 12, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | -- | Direct | -- | Feb 11, 2025 |
| SMITH HUNTER C Chief Financial Officer | -- | Direct | -- | Feb 11, 2025 |
| CRAMER PAMELA J. Officer | Sale at price 57.51 - 57.54 per share. | Direct | 40,315 | Feb 11, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 57.51 - 57.54 per share. | Direct | 45,663 | Feb 11, 2025 |
| SMITH HUNTER C Chief Financial Officer | Sale at price 57.51 - 57.53 per share. | Direct | 74,533 | Feb 11, 2025 |
| CRAMER PAMELA J. Officer | -- | Direct | -- | Feb 7, 2025 |
| LEE JENNIFER KAYDEN Officer | Sale at price 60.08 - 61.95 per share. | Direct | 185,640 | Feb 5, 2025 |
| LEE JENNIFER KAYDEN Officer | Sale at price 59.43 per share. | Direct | 85,995 | Feb 4, 2025 |
| CRAMER PAMELA J. Officer | Sale at price 59.43 per share. | Direct | 53,606 | Feb 4, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 59.43 per share. | Direct | 76,130 | Feb 4, 2025 |
| MEEKER DAVID P Chief Executive Officer | Sale at price 59.43 per share. | Direct | 254,242 | Feb 4, 2025 |
| SMITH HUNTER C Chief Financial Officer | Sale at price 59.43 per share. | Direct | 99,724 | Feb 4, 2025 |
| MEEKER DAVID P Chief Executive Officer | -- | Direct | -- | Jan 31, 2025 |
| CRAMER PAMELA J. Officer | -- | Direct | -- | Jan 31, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | -- | Direct | -- | Jan 31, 2025 |
| SMITH HUNTER C Chief Financial Officer | -- | Direct | -- | Jan 31, 2025 |
| LEE JENNIFER KAYDEN Officer | -- | Direct | -- | Jan 31, 2025 |
| SHULMAN JOSEPH Chief Technology Officer | Conversion of Exercise of derivative security at price 6.80 - 21.38 per share. | Direct | 167,760 | Nov 11, 2024 |
| LEE JENNIFER KAYDEN Officer | Conversion of Exercise of derivative security at price 6.80 - 30.66 per share. | Direct | 1,194,709 | Nov 11, 2024 |
| LEE JENNIFER KAYDEN Officer | Sale at price 65.68 - 68.43 per share. | Direct | 4,434,882 | Nov 11, 2024 |
| SHULMAN JOSEPH Chief Technology Officer | Sale at price 65.73 - 67.83 per share. | Direct | 882,341 | Nov 11, 2024 |
| CRAMER PAMELA J. Officer | Conversion of Exercise of derivative security at price 19.02 per share. | Direct | 178,312 | Nov 7, 2024 |
| CRAMER PAMELA J. Officer | Sale at price 60.00 - 65.00 per share. | Direct | 585,940 | Nov 7, 2024 |
Related Tickers
SLNO Soleno Therapeutics, Inc.
76.26
+2.14%
ASND Ascendis Pharma A/S
159.39
-0.99%
CRNX Crinetics Pharmaceuticals, Inc.
32.70
+4.17%
PTGX Protagonist Therapeutics, Inc.
43.92
+1.93%
BPMC Blueprint Medicines Corporation
98.76
-1.04%
AKRO Akero Therapeutics, Inc.
42.39
-0.93%
RVMD Revolution Medicines, Inc.
41.91
+11.29%
SRRK Scholar Rock Holding Corporation
30.99
+4.34%
MIRM Mirum Pharmaceuticals, Inc.
45.24
+9.75%
KYMR Kymera Therapeutics, Inc.
30.77
+5.70%